Showing results (811-820 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 5, 2005
Advances in drug treatments for children and adolescents with autism and other pervasive developmental disordersRichard P Malone, Silvia S Gratz, Mary Anne Delaney, et al.CNS Drugs|November 5, 2005
Rotigotine: in Parkinson's diseaseNeil A Reynolds, Keri Wellington, Stephanie E EasthopeCNS Drugs|June 13, 2025
Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment TargetsAbbas F Almulla, Michael MaesCNS Drugs|July 18, 2025
Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension TrialAlpesh Shah, Alvin Estilo, Pamela L Sheridan, et al.CNS Drugs|October 10, 2025
Effect of Atogepant on Sleep Quality and Sleep-Related Adverse Events in Adult Patients with Migraine: A Prospective Observational 12-Week StudyLuigi Francesco Iannone, Alberto Boccalini, Flavia Lo Castro, et al.CNS Drugs|September 30, 2025
Estimating Changes in Clinical Outcomes after Discontinuation of Anti-CGRP Targeting Therapy for Migraine Prophylaxis: A Systematic Review and Meta-analysisLuana Miyahira Makita, Thales Pardini Fagundes, Pedro Henrique Reginato, et al.CNS Drugs|July 23, 2025
Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic ReviewChristoph U CorrellCNS Drugs|December 15, 2025
Assessing Cognitive Function over Time in Patients with Refractory Chronic Migraine Who Received Ketamine Infusions: A Prospective, Observational StudyMarianna Vinokur, Eric S Schwenk, Sawsan Alabad, et al.CNS Drugs|April 11, 2025
Effect of Naltrexone on Spinal and Supraspinal Pain Mechanisms and Functional Capacity in Women with Fibromyalgia: Exploratory Outcomes from the Randomized Placebo-Controlled FINAL TrialKarin Due Bruun, Robin Christensen, Kirstine Amris, et al.CNS Drugs|April 3, 2025
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and FunctionBruce A C Cree, Joseph R Berger, Benjamin GreenbergPageof 211